Abner Herrman & Brock LLC Zoetis Inc. Transaction History

Abner Herrman & Brock LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 09, 2021	SELL	$144.0 - $169.39 $211,248 - $248,495	-1,467 Closed	0 $0
Q4 2020 Jan 12, 2021	BUY	$157.07 - $174.35 $4,397 - $4,881	28 Added 1.95%	1,467 $243,000
Q3 2020 Oct 08, 2020	SELL	$137.1 - $165.37 $37,428 - $45,146	-273 Reduced 15.95%	1,439 $238,000
Q1 2020 Apr 09, 2020	SELL	$92.66 - $144.94 $11,675 - $18,262	-126 Reduced 6.86%	1,712 $201,000
Q3 2019 Oct 11, 2019	BUY	$112.57 - $128.43 $8,105 - $9,246	72 Added 4.08%	1,838 $229,000
Q2 2019 Jul 19, 2019	BUY	$97.98 - $114.28 $173,032 - $201,818	1,766 New	1,766 $200,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

Stay updated on Abner Herrman & Brock LLC with notifications on news.